ArticleCureus2026

Early-Onset Immune Checkpoint Inhibitor-Induced Myasthenia Gravis Following First-Cycle Pembrolizumab: Diagnostic Challenges and Management Strategies.

Ziad Gaafar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.